Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1Phase 3 1

Status

Completed 6Unknown 5Terminated 4Withdrawn 2Recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Carcinoma, Hepatocellular 4Recurrence 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Liver Neoplasms 1

Interventions

Oxaliplatin 288Capecitabine 218Fluorouracil 212Irinotecan 145Leucovorin 139Gemcitabine 124S 1 (combination) 110apatinib 109Cisplatin 102Drug Therapy 98Bevacizumab 98Radiotherapy 97Paclitaxel 97camrelizumab 89sintilimab 79Cetuximab 75lenvatinib 62Neoadjuvant Therapy 61tislelizumab 55Surgical Procedures, Operative 54Sorafenib 53Folfox protocol 53toripalimab 52Docetaxel 52130-nm albumin-bound paclitaxel 47Laparoscopy 41HMPL-013 40XELOX 39Radiosurgery 36Albumin-Bound Paclitaxel 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × Chemoembolization, Therapeutic × Gastrointestinal × Clear all
NCT04764409 2021-02-21

PATOC

Central Clinical Hospital RZD-Medicine, Russian Federation

Unknown
500 enrolled
Gastrointestinal

Liver Neoplasms, Neoplasm Metastasis

NCT01393093 2017-06-12

TACE-KMG

Tianjin Medical University Cancer Institute and Hospital

Phase NA Unknown
2,840 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02301091 2016-04-14

CORTT

Sun Yat-sen University

Phase 3 Unknown
240 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02631499 2015-12-22

Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation

Fudan University

Phase 4 Unknown
256 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Neoplastic Cells, Circulating, Recurrence

NCT01393197 2015-12-18

TACE-KMG

Tianjin Medical University Cancer Institute and Hospital

Phase NA Unknown
2,480 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡